CereVasc wins FDA IDE to expand eShunt trial : comparemela.c

CereVasc wins FDA IDE to expand eShunt trial

CereVasc announced today that the FDA approved an investigational device exemption (IDE) supplement for a study of its eShunt system.

Related Keywords

Carl Heilman , Pedro Lylyk , Adel Malek , Dan Levangie , , Shunt System ,

© 2025 Vimarsana